412984402	412984402	CD	B-NP	O
|	|	NNP	I-NP	O
WMC	WMC	NNP	I-NP	O
|	|	VBD	B-VP	O
30575632	30575632	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
857556	857556	CD	B-NP	O
|	|	CC	I-NP	O
8/5/2001	8/5/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ACUTE	ACUTE	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/14/2001	2/14/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/5/2001	3/5/2001	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
INFERIOR	INFERIOR	NN	B-NP	O
MYOCARDIAL	MYOCARDIAL	NN	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

LEFT	LEFT	NNP	B-NP	O
FRONTAL	FRONTAL	NNP	I-NP	O
LOBE	LOBE	NNP	I-NP	O
MENINGIOMA	MENINGIOMA	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

DIASTOLIC	DIASTOLIC	NN	B-NP	O
DYSFUNCTION	DYSFUNCTION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Testani	Testani	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
+	+	SYM	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
prior	prior	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ie	Ie	NNP	I-NP	O
Health	Health	NNP	I-NP	O
on	on	IN	B-PP	O
2/14/01	2/14/01	CD	B-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
lasting	last	VBG	B-VP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
in	in	RP	B-PRT	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
great	great	JJ	I-NP	O
granddaughter	granddaughter	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ST	ST	JJ	B-NP	O
segment	segment	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
inferiorly	inferiorly	RB	B-ADVP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Hobert	Hobert	NNP	B-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
emergent	emergent	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
,	,	,	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
,	,	,	I-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	I-NP	O
nitropaste	nitropaste	NN	I-NP	O
,	,	,	I-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
sent	send	VBN	B-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
mid	mid	NN	B-NP	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
80	80	CD	I-NP	O
percent	percent	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
100	100	CD	I-NP	O
percent	percent	NN	I-NP	O
posterior	posterior	RB	B-VP	O
descending	descend	VBG	I-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
was	be	VBD	B-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
and	and	CC	O	O
stented	stente	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
0	0	CD	B-NP	O
percent	percent	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
complications	complication	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
intensive	intensive	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
hematoma	hematoma	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
frontal	frontal	JJ	B-NP	O
lobe	lobe	NN	I-NP	O
meningioma	meningioma	NN	I-NP	O
as	as	IN	B-SBAR	O
documented	document	VBN	B-VP	O
by	by	IN	B-PP	O
MRI	MRI	NN	B-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
dose	dose	NN	I-NP	O
unknown	unknown	JJ	B-ADJP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	O	O
meclizine	meclizine	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/70	140/70	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
94	94	CD	B-NP	O
percent	percent	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
Awake	Awake	NNP	B-NP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Crackles	Crackles	NNP	B-NP	O
present	present	VBP	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
both	both	CC	O	O
lung	lung	NN	B-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
,	,	,	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

II/VI	II/VI	LS	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
radiation	radiation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
plus	plus	CC	O	O
dorsalis	dorsalis	NN	B-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Neurologic	Neurologic	JJ	B-NP	O
status	status	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Nonfocal	Nonfocal	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
13.6	13.6	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39	39	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
222	222	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	B-protein
141	141	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
100	100	CD	I-NP	I-cell_line
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
37	37	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.0	2.0	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
192	192	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
was	be	VBD	B-VP	O
11	11	CD	B-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-DNA
23	23	CD	I-NP	I-DNA
,	,	,	O	O
INR	INR	NN	B-NP	O
0.88	0.88	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
number	number	NN	I-NP	O
one	one	CD	I-NP	O
is	be	VBZ	B-VP	O
216	216	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
done	do	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
number	number	NN	I-NP	O
two	two	CD	B-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
2577	2577	CD	I-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-cell_line
310	310	CD	I-NP	I-cell_line
,	,	,	O	O
troponin	troponin	NN	B-NP	O
3.49	3.49	CD	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
pre-catheterization	pre-catheterization	NN	I-NP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
of	of	IN	B-PP	O
75	75	CD	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
millimeter	millimet	JJR	I-NP	O
ST	ST	JJ	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
after	after	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
peak	peak	JJ	I-NP	I-protein
CK	CK	NN	I-NP	I-protein
was	be	VBD	B-VP	O
2577	2577	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
310	310	CD	B-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
3.49	3.49	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
initial	initial	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
10/10/01	10/10/01	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
had	have	VBD	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
to	to	TO	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
pseudo	pseudo	NN	B-NP	O
normalization	normalization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
waves	wave	VBZ	B-VP	O
laterally	laterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CKs	CK	NNS	I-NP	B-protein
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
however	however	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
of	of	IN	B-PP	O
further	further	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	O	O
brought	bring	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O
on	on	IN	B-PP	O
6/27/01	6/27/01	CD	B-NP	O
for	for	IN	B-PP	O
stenting	stente	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
stent	stent	NN	I-NP	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
well	well	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CKs	CK	NNS	I-NP	B-protein
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
percent	percent	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
posterior	posterior	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
with	with	IN	B-PP	O
plans	plan	NNS	B-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NN	B-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
a	a	DT	B-NP	O
rising	rise	VBG	I-NP	O
creatinine	creatinine	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
her	her	PRP$	B-NP	O
Zestril	Zestril	NNP	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stopped	stop	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
normalizes	normalize	VBZ	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
which	which	WDT	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
4.0	4.0	CD	B-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
second	second	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
is	be	VBZ	B-VP	O
deemed	deem	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
contrast	contrast	NN	B-NP	O
induced	induced	JJ	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
improving	improve	VBG	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
3.2	3.2	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Zestril	Zestril	NNP	I-NP	O
restarted	restart	VBD	B-VP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
stopped	stop	VBD	B-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
normalizes	normalize	VBZ	B-VP	O
to	to	TO	B-PP	O
below	below	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
drop	drop	VB	I-VP	O
to	to	TO	B-PP	O
27	27	CD	B-NP	O
slowly	slowly	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
guaiac	guaiac	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
above	above	IN	B-PP	O
30	30	CD	B-NP	O
and	and	CC	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
34	34	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
consumes	consume	VBZ	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Psychiatry/neurologic	Psychiatry/neurologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
sun	sun	VB	I-VP	O
down	down	RP	B-PRT	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
confusion	confusion	NN	B-NP	O
and	and	CC	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
psychiatry	psychiatry	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
behavior	behavior	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
dementia	dementia	NN	B-NP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
starting	start	VBG	I-VP	O
Zyprexa	Zyprexa	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
Zyprexa	Zyprexa	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
agitation	agitation	NN	B-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
frontal	frontal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
mass	mass	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
meningioma	meningioma	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
and	and	CC	I-NP	O
MRI	MRI	NN	I-NP	O
scans	scan	NNS	I-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

Neurosurgery	Neurosurgery	NN	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
surgery	surgery	NN	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
option	option	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
they	they	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mass	mass	NN	I-NP	O
was	be	VBD	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
RPR	RPR	NN	I-NP	I-protein
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
syphilis	syphilis	NN	B-NP	O
with	with	IN	B-PP	O
benzathine	benzathine	NN	B-NP	B-DNA
penicillin	penicillin	NN	I-NP	I-DNA
2.4	2.4	CD	I-NP	I-DNA
million	million	CD	I-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
times	times	CC	O	O
three	three	CD	B-NP	O
injections	injection	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
one	one	CD	B-NP	O
injection	injection	NN	I-NP	O
pending	pending	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
on	on	IN	B-PP	O
3/5/01	3/5/01	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
lumbar	lumbar	NN	I-NP	O
puncture	puncture	NN	I-NP	O
for	for	IN	B-PP	O
neurologic	neurologic	JJ	B-NP	O
syphilis	syphilis	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Chora	Chora	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
eventual	eventual	JJ	B-NP	O
plans	plan	NNS	I-NP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ernesto	Ernesto	NNP	I-NP	O
Fouch	Fouch	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Crestsant	Crestsant	NNP	I-NP	O
Health	Health	NNP	I-NP	O
on	on	IN	B-PP	O
2/2/01	2/2/01	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	B-protein
650	650	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
4	4	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Robitussin	Robitussin	NNP	B-NP	O
15	15	CD	I-NP	O
cc	cc	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
Plan	Plan	NNP	I-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
hydralazine	hydralazine	NN	B-NP	O
when	when	WRB	B-ADVP	O
creatinine	creatinine	NN	B-NP	O
returns	return	NNS	I-NP	O
below	below	IN	B-PP	O
2.0	2.0	CD	B-NP	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
Zestril	Zestril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
benzathine	benzathine	NN	I-NP	I-protein
2.4	2.4	CD	I-NP	I-protein
million	million	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
IM	IM	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
last	last	JJ	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
3/5/01	3/5/01	CD	B-NP	O
.	.	.	O	O

Percocet	Percocet	IN	B-PP	O
1-2	1-2	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
8	8	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
osteoarthritic	osteoarthritic	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
HS	HS	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zyprexa	Zyprexa	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
times	time	VBZ	B-VP	O
24	24	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
JASPER	JASPER	NNP	B-NP	O
BUTTEL	BUTTEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD75	AD75	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FILIBERTO	FILIBERTO	NNP	B-NP	O
WILTON	WILTON	NNP	I-NP	O
PILLERS	PILLERS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HD3	HD3	NNP	I-NP	O
IP030/3332	IP030/3332	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
2805	2805	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

C9GBEC5WB9	C9GBEC5WB9	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/8/01	11/8/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/8/01	11/8/01	CD	B-NP	O
cc	cc	NN	I-NP	O
:	:	:	O	O
Cordell	Cordell	NNP	B-NP	O
Zakowski	Zakowski	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O

